Vargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, et al
Tirzepatide & Zepbound Weight Loss Physician-guided Tirzepatide and Zepbound weight loss consultations for eligible Tampa patients
Glucocerebrosidase targeting therapies Glucocerebrosidase (GCase) is a 497 amino-acid lysosomal hydroxylase, which degrades glucocerebroside into ceramide and glucose (Boer et al
Reconstitution of the complete rupture in musculotendinous junction using skeletal muscle-derived multipotent stem cell sheet-pellets as a "bio-bond
lower waist size, blood pressure, and cholesterol) compared with those taking a placebo
The companys leadership, led by new CEO Maziar "Mike" Doustdar, cited a "painful transition" as the primary reason for the downgrade, acknowledging that the era of $1,000-per-month GLP-1 prices in the U.S